Home>Topics>Stocks>Exelixis

Exelixis EXEL

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick

      Headlines

      Tue, 16 Sep 2014

      Investor : A Greenblatt Magic Formula screen for drug companies with market cap> $500M on 10/17/2012 identified Exelixis (NASDAQ: EXEL ), Momenta (NASDAQ: MNTA ), Pozen (NASDAQ: POZN ), and Questcor (NASDAQ: QCOR ). An equally weighted

    2. Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious

      Headlines

      Mon, 15 Sep 2014

      By Don Dion : Tokai Pharmaceuticals Inc (Pending: TKAI ), a clinical-stage biopharmaceutical company engaged in the development of novel treatments for prostate cancer, plans to raise $75.6 million in its upcoming IPO. The Cambridge, Massachusetts-based firm will offer 5.4 million shares at an ...

    3. Exelixis' ( EXEL ) CEO Michael Morrissey Presents at Morgan Stanley Healthcare Conference (Transcript)

      Headlines

      Tue, 9 Sep 2014

      By SA Transcripts : Exelixis , Inc. (NASDAQ: EXEL ) Morgan Stanley Healthcare Conference ..... s my pleasure to introduce Exelixis , a biopharmaceutical company ..... Joining me here on stage from Exelixis is Dr. Michael Morrissey, the

    4. Update: Exelixis COMET-1 Trial Fails: The Impact To My Bull Thesis

      Headlines

      Tue, 2 Sep 2014

      By Christopher F. Davis : Exelixis , Inc. (NASDAQ: EXEL ) just announced top-line results from the final analysis of its COMET-1 phase 3 pivotal trial of cabozantinib (Cometriq

    5. Midday Gainers / Losers

      Headlines

      Tue, 2 Sep 2014

      ISNS +36% . OTCQB:ADMP +25% . HGSH +22% . EFUT +21% . ASTI +19% . OTC:VGGL +18% . SSY +17% . Top 10 Losers: EXEL -53% . CONN -30% . RSH -19% . OTC:RIBT -18% . ALDR -15% . IVAN -13% . SGOC -11% . CRRS -10% . RLJE -10

    6. Exelixis' ( EXEL ) CEO Mike Morrissey Hosts COMET-1 Results Conference (Transcript)

      Headlines

      Tue, 2 Sep 2014

      By SA Transcripts : Exelixis , Inc. (NASDAQ: EXEL ) COMET-1 Results Conference Call September 2, 2014 8:30 AM ET Executives ..... Operator Good day ladies and gentlemen and welcome to the Exelixis ’ COMET-1 PT Results Conference Call. My name is Alex

    7. New Morningstar Analyst Report for Exelixis Inc

      Stock Reports

      Tue, 2 Sep 2014

      While Exelixis boasts a vast clinical lineup, only one of its drugs has ..... indication raises questions about the full potential of Exelixis ' key oncology program.Although Exelixis ' diverse clinical lineup helps distinguish it from its

    8. Premarket Gainers / Losers

      Headlines

      Tue, 2 Sep 2014

      Gainers: HGSH +39% . EFUT +26% . DGLY +19% . ASTI +18% . ACAD +15% . CPWR +14% . NCLH +13% . ISNS +6% . LIQD +5% . SPLS +5% . Losers: EXEL -53% . CONN -28% . OTC:RIBT -18%. Post your comment!

    9. US STOCKS-Wall St set for flat open; manufacturing data on tap

      Headlines

      Tue, 2 Sep 2014

      * Exelixis tumbles after cancer drug fails study; to cut jobs

    10. US STOCKS-Futures inch higher ahead of manufacturing data

      Headlines

      Tue, 2 Sep 2014

      * Exelixis tumbles after cancer drug fails study; to cut jobs

    « Prev12345Next »
    Content Partners